Metabolic benefits of dietary prebiotics in human subjects: A systematic review of randomised controlled trials

British Journal of Nutrition

Volumn 111, Issue 7, 2014, Pages 1147-1161

  Kellow, Nicole J ^a   Coughlan, Melinda T ^a,b   Reid, Christopher M ^a  

^a MONASH UNIVERSITY   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Gut microflora; Human subjects; Metabolic disorders; Prebiotics

Indexed keywords

C REACTIVE PROTEIN; CHOLECYSTOKININ; CHOLESTEROL; CYTOKINE; FATTY ACID; FRUCTOSAMINE; FRUCTOSE OLIGOSACCHARIDE; GALACTOSE OLIGOSACCHARIDE; GHRELIN; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; INSULIN; INULIN; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; PEPTIDE YY; PREBIOTIC AGENT; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

BODY WEIGHT; CALORIC INTAKE; CHRONIC INFLAMMATION; DIET SUPPLEMENTATION; DYSLIPIDEMIA; FATTY LIVER; GASTROESOPHAGEAL REFLUX; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HUMAN; HYPERCHOLESTEROLEMIA; IMMUNE RESPONSE; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; INTESTINE FLORA; MALNUTRITION; MEDICAL RESEARCH; METABOLIC REGULATION; METABOLIC SYNDROME X; MICROBIAL ACTIVITY; MICROBIAL GROWTH; NON INSULIN DEPENDENT DIABETES MELLITUS; NONALCOHOLIC FATTY LIVER; OBESITY; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SATIETY; SELF REPORT; STOMACH EMPTYING; SYSTEMATIC REVIEW; TREATMENT DURATION; VOLUNTEER; ADULT; ANIMAL; HEALTH PROMOTION; HYPERGLYCEMIA; HYPERINSULINISM; IMMUNOLOGY; INTESTINE; META ANALYSIS; MICROBIOLOGY; PHYSIOLOGY; PSYCHOPHYSIOLOGY; REPRODUCIBILITY;

BACTERIA (MICROORGANISMS);

ADULT; ANIMALS; HEALTH PROMOTION; HUMANS; HYPERGLYCEMIA; HYPERINSULINISM; INTESTINES; POSTPRANDIAL PERIOD; PREBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; SATIETY RESPONSE;

EID: 84900509172     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114513003607     Document Type: Review

References (90)

1. Diamant M, Blaak EE & de Vos WM (2011) Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes? Obes Rev 12, 272-281.
2. Wu X, Ma C, Han L, et al. (2010) Molecular characterisation of the faecal microbiota in patients with type II diabetes. Curr Microbiol 61, 69-78.
3. Larsen N, Vogensen FK, van den Berg FW, et al. (2010) Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS ONE 5, e9085.
4. Gibson GR, Probert HM, Loo JV, et al. (2004) Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 17, 259-275.
5. Roberfroid M, Gibson GR, Hoyles L, et al. (2010) Prebiotic effects: metabolic and health benefits. Br J Nutr 104, Suppl. 2, S1-S63.
6. Ramirez-Farias C, Slezak K, Fuller Z, et al. (2009) Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii. Br J Nutr 101, 541-550.
7. Chung H & Kasper DL (2010) Microbiota-stimulated immune mechanisms to maintain gut homeostasis. Curr Opin Immunol 22, 455-460.
8. Ding S, Chi MM, Scull BP, et al. (2010) High-fat diet: bacteria interactions promote intestinal inflammation which precedes and correlates with obesity and insulin resistance in mouse. PLoS ONE 5, e12191.
9. Backhed F, Manchester JK, Semenkovich CF, et al. (2007) Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A 104, 979-984.
10. Havenaar R (2011) Intestinal health functions of colonic microbial metabolites: a review. Benef Microbes 2, 103-114.
11. Cani PD, Neyrinck AM, Fava F, et al. (2007) Selective increases of bifidobacteria in gut microflora improve highfat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 50, 2374-2383.
12. Cani PD, Possemiers S, Van de Wiele T, et al. (2009) Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 58, 1091-1103.
13. Hill MJ (1997) Intestinal flora and endogenous vitamin synthesis. Eur J Cancer Prev 6, Suppl. 1, S43-S45.
14. Scholz-Ahrens KE, Ade P, Marten B, et al. (2007) Prebiotics, probiotics, and synbiotics affect mineral absorption, bone mineral content, and bone structure. J Nutr 137, 838S-846S.
15. Musso G, Gambino R & Cassader M (2011) Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annu Rev Med 62, 361-380.
16. Neyrinck AM & Delzenne NM (2010) Potential interest of gut microbial changes induced by non-digestible carbohydrates of wheat in the management of obesity and related disorders. Curr Opin Clin Nutr Metab Care 13, 722-728.
17. Cloetens L, Ulmius M, Johansson-Persson A, et al. (2012) Role of dietary beta-glucans in the prevention of the metabolic syndrome. Nutr Rev 70, 444-458.
18. Kootte RS, Vrieze A, Holleman F, et al. (2012) The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus. Diabetes Obes Metab 14, 112-120.
19. Heyland DK, Novak F, Drover JW, et al. (2001) Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA 286, 944-953.
20. White IR & Thomas J (2005) Standardized mean differences in individually-randomized and cluster-randomized trials, with applications to meta-analysis. Clin Trials 2, 141-151.
21. Bunout D, Hirsch S, Pia de la Maza M, et al. (2002) Effects of prebiotics on the immune response to vaccination in the elderly. JPEN J Parenter Enteral Nutr 26, 372-376.
22. Cani PD, Joly E, Horsmans Y, et al. (2006) Oligofructose promotes satiety in healthy human: a pilot study. Eur J Clin Nutr 60, 567-572.
23. Cani PD, Lecourt E, Dewulf EM, et al. (2009) Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr 90, 1236-1243.
24. Causey JL (2000) Effects of dietary inulin on serum lipids, blood glucose and the gastrointestinal environment in hypercholesterolemic men. Nutr Res 20, 191-201.
25. Daubioul CA, Horsmans Y, Lambert P, et al. (2005) Effects of oligofructose on glucose and lipid metabolism in patients with nonalcoholic steatohepatitis: results of a pilot study. Eur J Clin Nutr 59, 723-726.
26. Dehghan P, Gargari BP, Jafar-Abadi MA, et al. (2013) Inulin controls inflammation and metabolic endotoxemia in women with type 2 diabetes mellitus: a randomizedcontrolled clinical trial. Int J Food Sci Nutr (Epublication ahead of print version 24 September 2013).
27. Pourghassem Gargari B, Dehghan P, Aliasgharzadeh A, et al. (2013) Effects of high performance inulin supplementation on glycemic control and antioxidant status in women with type 2 diabetes. Diabetes Metab J 37, 140-148.
28. de Luis DA, de la Fuente B, Izaola O, et al. (2011) Double blind randomized clinical trial controlled by placebo with an alpha linoleic acid and prebiotic enriched cookie on risk cardiovascular factor in obese patients. Nutr Hosp 26, 827-833.
29. Dewulf EM, Cani PD, Claus SP, et al. (2013) Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut 62, 1112-1121.
30. Genta S, Cabrera W, Habib N, et al. (2009) Yacon syrup: beneficial effects on obesity and insulin resistance in humans. Clin Nutr 28, 182-187.
31. Giacco R, Clemente G, Luongo D, et al. (2004) Effects of short-chain fructo-oligosaccharides on glucose and lipid metabolism in mild hypercholesterolaemic individuals. Clin Nutr 23, 331-340.
32. Lecerf JM, Depeint F, Clerc E, et al. (2012) Xylo-oligosaccharide (XOS) in combination with inulin modulates both the intestinal environment and immune status in healthy subjects, while XOS alone only shows prebiotic properties. Br J Nutr 108, 1847-1858.
33. Letexier D, Diraison F & Beylot M (2003) Addition of inulin to a moderately high-carbohydrate diet reduces hepatic lipogenesis and plasma triacylglycerol concentrations in humans. Am J Clin Nutr 77, 559-564.
34. Lomax AR, Cheung LV, Tuohy KM, et al. (2012) b2-1 Fructans have a bifidogenic effect in healthy middle-aged human subjects but do not alter immune responses examined in the absence of an in vivo immune challenge: results from a randomised controlled trial. Br J Nutr 108, 1818-1828.
35. Luo J, Van Yperselle M, Rizkalla SW, et al. (2000) Chronic consumption of short-chain fructooligosaccharides does not affect basal hepatic glucose production or insulin resistance in type 2 diabetics. J Nutr 130, 1572-1577.
36. Parnell JA & Reimer RA (2009) Weight loss during oligofructose supplementation is associated with decreased ghrelin and increased peptide YY in overweight and obese adults. Am J Clin Nutr 89, 1751-1759.
37. Peters HP, Boers HM, Haddeman E, et al. (2009) No effect of added beta-glucan or of fructooligosaccharide on appetite or energy intake. Am J Clin Nutr 89, 58-63.
38. Piche T, des Varannes SB, Sacher-Huvelin S, et al. (2003) Colonic fermentation influences lower esophageal sphincter function in gastroesophageal reflux disease. Gastroenterology 124, 894-902.
39. Russo F, Chimienti G, Riezzo G, et al. (2008) Inulin-enriched pasta affects lipid profile and Lp(a) concentrations in Italian young healthy male volunteers. Eur J Nutr 47, 453-459.
40. Russo F, Riezzo G, Chiloiro M, et al. (2010) Metabolic effects of a diet with inulin-enriched pasta in healthy young volunteers. Curr Pharm Des 16, 825-831.
41. Russo F, Clemente C, Linsalata M, et al. (2011) Effects of a diet with inulin-enriched pasta on gut peptides and gastric emptying rates in healthy young volunteers. Eur J Nutr 50, 271-277.
42. Russo F, Linsalata M, Clemente C, et al. (2012) Inulinenriched pasta improves intestinal permeability and modifies the circulating levels of zonulin and glucagon-like peptide 2 in healthy young volunteers. Nutr Res 32, 940-946.
43. Schiffrin EJ, Thomas DR, Kumar VB, et al. (2007) Systemic inflammatory markers in older persons: the effect of oral nutritional supplementation with prebiotics. J Nutr Health Aging 11, 475-479.
44. Seidel C, Boehm V, Vogelsang H, et al. (2007) Influence of prebiotics and antioxidants in bread on the immune system, antioxidative status and antioxidative capacity in male smokers and non-smokers. Br J Nutr 97, 349-356.
45. Tovar AR, Caamano Mdel C, Garcia-Padilla S, et al. (2012) The inclusion of a partial meal replacement with or without inulin to a calorie restricted diet contributes to reach recommended intakes of micronutrients and decrease plasma triglycerides: a randomized clinical trial in obese Mexican women. Nutr J 11, 44.
46. Verhoef SP, Meyer D & Westerterp KR (2011) Effects of oligofructose on appetite profile, glucagon-like peptide 1 and peptide YY3-36 concentrations and energy intake. Br J Nutr 106, 1757-1762.
47. Vulevic J, Drakoularakou A, Yaqoob P, et al. (2008) Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers. Am J Clin Nutr 88, 1438-1446.
48. Vulevic J, Juric A, Tzortzis G, et al. (2013) A mixture of transgalactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults. J Nutr 143, 324-331.
49. Whelan K, Efthymiou L, Judd PA, et al. (2006) Appetite during consumption of enteral formula as a sole source of nutrition: the effect of supplementing pea-fibre and fructooligosaccharides. Br J Nutr 96, 350-356.
50. Flint HJ, Scott KP, Louis P, et al. (2012) The role of the gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol 9, 577-589.
51. Cani PD, Hoste S, Guiot Y, et al. (2007) Dietary nondigestible carbohydrates promote L-cell differentiation in the proximal colon of rats. Br J Nutr 98, 32-37.
52. Gao Z, Yin J, Zhang J, et al. (2009) Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes 58, 1509-1517.
53. Backhed F, Ding H, Wang T, et al. (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci U S A 101, 15718-15723.
54. Aronsson L, Huang Y, Parini P, et al. (2010) Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4). PLoS ONE 5, e13087.
55. Parnell JA & Reimer RA (2012) Prebiotic fiber modulation of the gut microbiota improves risk factors for obesity and the metabolic syndrome. Gut Microbes 3, 29-34.
56. Everard A, Lazarevic V, Derrien M, et al. (2011) Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 60, 2775-2786.
57. Nyman M (2002) Fermentation and bulking capacity of indigestible carbohydrates: the case of inulin and oligofructose. Br J Nutr 87, Suppl. 2, S163-S168.
58. Perrigue MM, Monsivais P & Drewnowski A (2009) Added soluble fiber enhances the satiating power of low-energydensity liquid yogurts. J Am Diet Assoc 109, 1862-1868.
59. Tarini J & Wolever TM (2010) The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects. Appl Physiol Nutr Metab 35, 9-16.
60. Costabile A, Klinder A, Fava F, et al. (2008) Whole-grain wheat breakfast cereal has a prebiotic effect on the human gut microbiota: a double-blind, placebo-controlled, crossover study. Br J Nutr 99, 110-120.
61. Freeland KR, Wilson C & Wolever TM (2010) Adaptation of colonic fermentation and glucagon-like peptide-1 secretion with increased wheat fibre intake for 1 year in hyperinsulinaemic human subjects. Br J Nutr 103, 82-90.
62. Serino M, Luche E, Gres S, et al. (2012) Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota. Gut 61, 543-553.
63. Cani PD, Amar J, Iglesias MA, et al. (2007) Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761-1772.
64. Cani PD, Osto M, Geurts L, et al. (2012) Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes 3, 279-288.
65. Nakamura YK & Omaye ST (2012) Metabolic diseases and pro-and prebiotics: Mechanistic insights. Nutr Metab (Lond) 9, 60.
66. Liang H, Hussey SE, Sanchez-Avila A, et al. (2013) Effect of lipopolysaccharide on inflammation and insulin action in human muscle. PLOS ONE 8, e63983.
67. Creely SJ, McTernan PG, Kusminski CM, et al. (2007) Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes. Am J Physiol Endocrinol Metab 292, E740-E747.
68. Amar J (2010) Energy intake is associated with endotoxemia induces adipose inflammation and insulin resistance in humans. Diabetes 59, 9.
69. Delzenne NM & Cani PD (2011) Interaction between obesity and the gut microbiota: relevance in nutrition. Annu Rev Nutr 31, 15-31.
70. Eun CS, Han DS, Lee SH, et al. (2006) Attenuation of colonic inflammation by PPARgamma in intestinal epithelial cells: effect on Toll-like receptor pathway. Dig Dis Sci 51, 693-697.
71. Lewis K, Lutgendorff F, Phan V, et al. (2010) Enhanced translocation of bacteria across metabolically stressed epithelia is reduced by butyrate. Inflamm Bowel Dis 16, 1138-1148.
72. Cani PD (2012) Crosstalk between the gut microbiota and the endocannabinoid system: impact on the gut barrier function and the adipose tissue. Clin Microbiol Infect 18, Suppl. 4, 50-53.
73. Garcia AL, Otto B, Reich SC, et al. (2007) Arabinoxylan consumption decreases postprandial serum glucose, serum insulin and plasma total ghrelin response in subjects with impaired glucose tolerance. Eur J Clin Nutr 61, 334-341.
74. Lu ZX, Walker KZ, Muir JG, et al. (2004) Arabinoxylan fibre improves metabolic control in people with type II diabetes. Eur J Clin Nutr 58, 621-628.
75. Guo Z, Liu XM, Zhang QX, et al. (2012) Effects of inulin on the plasma lipid profile of normolipidemic and hyperlipidemic subjects: a meta-analysis of randomized controlled trials. Clin Lipidol 7, 215-222.
76. Koren O, Spor A, Felin J, et al. (2011) Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci U S A 108, Suppl. 1, 4592-4598.
77. Wang Z, Klipfell E, Bennett BJ, et al. (2011) Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472, 57-63.
78. Baddini Feitoza A, Fernandes Pereira A, Ferreira da Costa N, et al. (2009) Conjugated linoleic acid (CLA): effect modulation of body composition and lipid profile. Nutr Hosp 24, 422-428.
79. Fava F, Lovegrove JA, Gitau R, et al. (2006) The gut microbiota and lipid metabolism: implications for human health and coronary heart disease. Curr Med Chem 13, 3005-3021.
80. Brighenti F (2007) Dietary fructans and serum triacylglycerols: a meta-analysis of randomized controlled trials. J Nutr 137, 2552S-2556S.
81. Henao-Mejia J, Elinav E, Jin C, et al. (2012) Inflammasomemediated dysbiosis regulates progression of NAFLD and obesity. Nature 482, 179-185.
82. Sheth AA & Garcia-Tsao G (2008) Probiotics and liver disease. J Clin Gastroenterol 42, Suppl. 2, S80-S84.
83. Gratz SW, Mykkanen H & El-Nezami HS (2010) Probiotics and gut health: a special focus on liver diseases. World J Gastroenterol 16, 403-410.
84. Malaguarnera M, Vacante M, Antic T, et al. (2012) Bifidobacterium longum with fructo-oligosaccharides in patients with non alcoholic steatohepatitis. Dig Dis Sci 57, 545-553.
85. Schley PD & Field CJ (2002) The immune-enhancing effects of dietary fibres and prebiotics. Br J Nutr 87, Suppl. 2, S221-S230.
86. Macfarlane GT & Macfarlane S (2011) Fermentation in the human large intestine: its physiologic consequences and the potential contribution of prebiotics. J Clin Gastroenterol 45, S120-S127.
87. Maslowski KM & Mackay CR (2011) Diet, gut microbiota and immune responses. Nat Immunol 12, 5-9.
88. Stoyanova S, Geuns J, Hideg E, et al. (2011) The food additives inulin and stevioside counteract oxidative stress. Int J Food Sci Nutr 62, 207-214.
89. Russell WR, Gratz SW, Duncan SH, et al. (2011) Highprotein, reduced-carbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic health. Am J Clin Nutr 93, 1062-1072.
90. Walton GE, van den Heuvel EG, Kosters MH, et al. (2012) A randomised crossover study investigating the effects of galacto-oligosaccharides on the faecal microbiota in men and women over 50 years of age. Br J Nutr 107, 1466-1475.